loading

Galectin Therapeutics Inc Borsa (GALT) Ultime notizie

pulisher
Jul 23, 2026

Galectin Therapeutics (NASDAQ:GALT) Breaks a Key Trend Line - Kalkine Media

Jul 23, 2026
pulisher
Jul 23, 2026

GALT stock reacts to Galectin Therapeutics Q1 2026 cash position and R&D progress - AD HOC NEWS

Jul 23, 2026
pulisher
Jul 23, 2026

Galectin Therapeutics (NASDAQ:GALT) Stock Passes Above 200-Day Moving AverageHere's Why - MarketBeat

Jul 23, 2026
pulisher
Jul 19, 2026

GALT stock gains support as Galectin Therapeutics keeps cash focus - AD HOC NEWS

Jul 19, 2026
pulisher
Jul 16, 2026

Form 4 Galectin Therapeutics Inc For: 16 July By Investing.com - Investing.com Nigeria

Jul 16, 2026
pulisher
Jul 16, 2026

Galectin Therapeutics CMO Jamil Khurram sells $83,284 in stock - Investing.com

Jul 16, 2026
pulisher
Jul 16, 2026

Galectin Therapeutics (GALT) CMO sells 16,250 shares under 10b5-1 plan - Stock Titan

Jul 16, 2026
pulisher
Jul 16, 2026

Galectin Therapeutics CMO Jamil Khurram disposes of 16,250 common shares for $83,284.5 - Bitget

Jul 16, 2026
pulisher
Jul 15, 2026

Can Galectin Therapeutics (NASDAQ:GALT) Regain Confidence? - Kalkine Media

Jul 15, 2026
pulisher
Jul 15, 2026

Galectin Therapeutics (NASDAQ:GALT) Stock Rating Lowered by Zacks Research - MarketBeat

Jul 15, 2026
pulisher
Jul 14, 2026

Price to book forward of Galectin Therapeutics Inc. – NASDAQ:GALT - TradingView

Jul 14, 2026
pulisher
Jul 11, 2026

$Galectin Therapeutics (GALT.US)$ - Moomoo

Jul 11, 2026
pulisher
Jul 11, 2026

$Galectin Therapeutics (GALT.US)$ put CMO at the table with who at solar? - Moomoo

Jul 11, 2026
pulisher
Jul 09, 2026

GALT jumps 11% on FDA alignment for belapectin phase III path in MASH - MSN

Jul 09, 2026
pulisher
Jul 09, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review

Jul 09, 2026
pulisher
Jul 07, 2026

Enterprise value to revenue forward of Galectin Therapeutics Inc. – NASDAQ:GALT - TradingView

Jul 07, 2026
pulisher
Jul 06, 2026

Price to sales forward of Galectin Therapeutics Inc. – NASDAQ:GALT - TradingView

Jul 06, 2026
pulisher
Jul 05, 2026

Galectin Therapeutics (GALT) Gains 4.16% as Biotech Momentum BuildsTriple Top - dars.gov.et

Jul 05, 2026
pulisher
Jul 04, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Galectin Ther - The National Law Review

Jul 04, 2026
pulisher
Jul 03, 2026

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review

Jul 03, 2026
pulisher
Jun 30, 2026

Form 4 Galectin Therapeutics Inc For: 30 June By Investing.com - Investing.com South Africa

Jun 30, 2026
pulisher
Jun 30, 2026

Galectin Therapeutics CMO Jamil Khurram disposes of $262,083 in stock - Investing.com

Jun 30, 2026
pulisher
Jun 30, 2026

Galectin Therapeutics CMO Jamil Khurram disposes of $262,083 in stock By Investing.com - Investing.com Nigeria

Jun 30, 2026
pulisher
Jun 30, 2026

Galectin Therapeutics director sells $150,890 in common stock By Investing.com - Investing.com South Africa

Jun 30, 2026
pulisher
Jun 30, 2026

[Form 4] GALECTIN THERAPEUTICS INC Insider Trading Activity - Stock Titan

Jun 30, 2026
pulisher
Jun 30, 2026

Galectin Therapeutics (GALT) CMO exits 52,037 shares in pre-planned sale - Stock Titan

Jun 30, 2026
pulisher
Jun 30, 2026

Top 3 Health Care Stocks That May Keep You Up At Night In June - Benzinga

Jun 30, 2026
pulisher
Jun 29, 2026

Galectin Therapeutics Inc.(NasdaqCM:GALT) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Harold Shlevin files Form 144: GALT (NASDAQ) sale of 7,732 shares - Stock Titan

Jun 29, 2026
pulisher
Jun 29, 2026

Galectin Therapeutics Inc.(NasdaqCM: GALT) added to Russell 2500 Growth Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Galectin Therapeutics Inc.(NasdaqCM: GALT) added to Russell 2000 Index - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Galectin Therapeutics (GALT) Slips 1.8% as Stock Tests Key Support at $4.66Volume Oscillator - dars.gov.et

Jun 29, 2026
pulisher
Jun 29, 2026

Galectin Therapeutics Inc.(NasdaqCM: GALT) added to Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Galectin Therapeutics Inc.(NasdaqCM: GALT) added to Russell 3000E Index - marketscreener.com

Jun 29, 2026
pulisher
Jun 28, 2026

Galectin Therapeutics Inc.(NasdaqCM: GALT) added to Russell 3000E Growth Benchmark - marketscreener.com

Jun 28, 2026
pulisher
Jun 28, 2026

Galectin Therapeutics Inc.(NasdaqCM:GALT) added to Russell Small Cap Completeness Index - marketscreener.com

Jun 28, 2026
pulisher
Jun 28, 2026

Galectin Therapeutics Inc.(NasdaqCM: GALT) added to Russell 3000 Growth Benchmark - marketscreener.com

Jun 28, 2026
pulisher
Jun 28, 2026

If you're not following me on stocktwits you probably should My money is on a partnership with Madrigal - Moomoo

Jun 28, 2026
pulisher
Jun 27, 2026

GALT stock surges 22% — on track for best day in over a year after FDA clears path for late-stage belapectin trial - MSN

Jun 27, 2026
pulisher
Jun 27, 2026

Form 144 GALECTIN THERAPEUTICS INC For: 26 June - Investing.com UK

Jun 27, 2026
pulisher
Jun 27, 2026

Galectin Therapeutics Inc (GALT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 27, 2026
pulisher
Jun 27, 2026

Form 144 GALECTIN THERAPEUTICS INC For: 26 June By Investing.com - Investing.com Nigeria

Jun 27, 2026
pulisher
Jun 26, 2026

GALT (NASDAQ: GALT) Rule 144 notice: Khurram Jamil reports share disposals - Stock Titan

Jun 26, 2026
pulisher
Jun 26, 2026

Form 144 GALECTIN THERAPEUTICS INCORPORATED For: 26 June By Investing.com - Investing.com Canada

Jun 26, 2026
pulisher
Jun 26, 2026

[144] GALECTIN THERAPEUTICS INC SEC Filing - Stock Titan

Jun 26, 2026
pulisher
Jun 26, 2026

GALTGalectin Therapeutics Inc Revenue Breakdown - Finviz

Jun 26, 2026
pulisher
Jun 26, 2026

$Galectin Therapeutics (GALT.US)$ The FIB Strikes Again!! - Moomoo

Jun 26, 2026
pulisher
Jun 26, 2026

Galectin Therapeutics Inc. Actuals & Estimates (FWB:PHPN) - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

GALT Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Galectin Therapeutics CMO Jamil Khurram sells $23,728 in shares By Investing.com - Investing.com South Africa

Jun 26, 2026
pulisher
Jun 25, 2026

Galectin Therapeutics CMO Jamil Khurram sells $23,728 in shares - Investing.com

Jun 25, 2026
pulisher
Jun 25, 2026

Form 4 Galectin Therapeutics Inc For: 25 June By Investing.com - Investing.com South Africa

Jun 25, 2026
$106.92
price down icon 0.46%
$117.67
price up icon 0.84%
$35.01
price down icon 0.26%
$58.83
price down icon 0.32%
ONC ONC
$325.90
price down icon 0.27%
$271.77
price up icon 1.13%
Capitalizzazione:     |  Volume (24 ore):